Cladis Investment Advisory’s GE HealthCare GEHC Stock Holding History

Cladis Investment Advisory’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Buy	17,623 +455	+3%	+$29.9K	0.53%	59
2026 Q1	$1.22M	Sell	17,168 -14	-0.1%	-$1.1K	0.67%	47
2025 Q4	$1.41M	Buy	17,182 +3,072	+22%	+$239K	0.77%	39
2025 Q3	$1.06M	Sell	14,110 -199	-1%	-$14.8K	0.61%	54
2025 Q2	$1.06M	Sell	14,309 -13	-0.1%	-$905	0.66%	48
2025 Q1	$1.16M	Sell	14,322 -84	-0.6%	-$7.22K	0.84%	36
2024 Q4	$1.13M	Sell	14,406 -420	-3%	-$35.7K	0.8%	42
2024 Q3	$1.39M	Buy	14,826 +188	+1%	+$15.8K	0.96%	32
2024 Q2	$1.14M	Buy	14,638 +224	+2%	+$18.3K	0.83%	36
2024 Q1	$1.31M	Sell	14,414 -149	-1%	-$12.4K	0.96%	34
2023 Q4	$1.13M	Buy	14,563 +1,826	+14%	+$128K	0.88%	36
2023 Q3	$867K	Buy	12,737 +4,341	+52%	+$316K	0.76%	43
2023 Q2	$682K	Buy	8,396 +109	+1%	+$8.7K	0.59%	57
2023 Q1	$680K	Buy	+8,287	New	+$592K	0.61%	59

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Cladis Investment Advisory's GEHC Position: Q2 2026 in Review

Cladis Investment Advisory increased its GE HealthCare (GEHC) stake by 2.7% in Q2 2026, buying an estimated $29.9K and bringing the position to 17,623 shares worth $1.13M. The position accounts for 0.53% of the portfolio, ranked #59.

Cladis Investment Advisory first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.41M in Q4 2025. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Cladis Investment Advisory held 17,623 shares of GE HealthCare worth $1.13M as of Q2 2026.
Cladis Investment Advisory bought 455 GE HealthCare shares in Q2 2026, an estimated $29.9K.
GE HealthCare made up 0.53% of Cladis Investment Advisory's portfolio in Q2 2026, its #59 holding.
Cladis Investment Advisory first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Cladis Investment Advisory's GE HealthCare position peaked at $1.41M in Q4 2025.
1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cladis Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.